Connecticut Senate Bill SB00188

Connecticut 2025 Regular Session

• Introduced: 1/8/25
• Refer: 1/8/25

Caption

An Act Concerning A State-operated Reinsurance Program And The Regulation Of Health Care Cost Growth.

Impact

The establishment of a state-operated reinsurance program is expected to directly impact the regulation of health care costs within the state. By implementing this program, the state aims to provide financial protection to enrollees and reduce the overall cost of health care. Additionally, the bill requires that the Office of Health Strategy adjust for any unintended effects that primary care spending targets might have particularly on individuals with developmental disabilities, ensuring that this vulnerable population is adequately supported.

Summary

SB00188, titled 'An Act Concerning a State-operated Reinsurance Program and the Regulation of Health Care Cost Growth,' aims to establish a state-operated reinsurance program designed to cover claims for specific health benefits under qualified health plans. The reinsurance program intends to mitigate the financial burden on both enrollees and the state by reallocating federal premium tax credits and cost-sharing reductions that would otherwise be awarded to enrollees, thus utilizing these funds to support the reinsurance efforts.

Contention

There may be debates surrounding the funding mechanisms for the reinsurance program, particularly concerning the federal waiver application and the implications it has for state funding. Opponents could argue about potential drawbacks, including the adequacy of supporting funds and the effects on health care providers. Moreover, the bill proposes the creation of a task force to study spread pricing in prescription drugs and evaluate potential savings from pooled purchasing models, highlighting ongoing concerns about prescription drug costs and access to essential medications.